Security key
74017N105
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 5,510,498
- Total 13F value
- $47,102,734
- Share change
- -758,042
- SEC-reported price per share
- $8.56
- Number of holders
- 43
- Value change
- -$6,491,666
- Number of buys
- 19
- Number of sells
- 9
- Shares outstanding
- 353,007,843
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
43
Top holders
10
PGEN full security history
Ownership snapshot
Full 13F holder table
PRECIGEN, INC. SEC filings
PRECIGEN, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74017N105
Recent filing periods:
Ownership snapshot
Top reported holders of PGEN - PRECIGEN, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Randal J. Kirk
Disclosed value leader
Randal J. Kirk
Comparable rows
5/15
Latest evidence
23 Aug 2026
3/4/5
13D/G
13F
Lead comparable stake: 36%
10 rows are not safely comparable across share classes.
13D/G row: Randal J. Kirk
Showing 1-6 of 15 holder rows.
Quick read
Randal J. Kirk leads the comparable SEC ownership view at 36%.
5 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Randal J. Kirk's linked filing trail.
Comparable ownership
Top 5
Randal J. Kirk
36%
Patient Capital Management, LLC
10%
William H. Miller III
9.2%
Merck KGaA
4.9%
Point72 Asset Management, L.P.
1.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Randal J. Kirk |
3/4/5
13D/G
Director, 10%+ Owner
|
36%
Reported 13D/G
· 30 Mar 2026
|
$399,586,241
117,527,718 shares
mixed-class rows
|
-$35,984,076 | 26 Mar 2026 |
| Patient Capital Management, LLC |
13D/G
13F
Company
|
10%
Reported 13D/G
· 31 Dec 2025
|
$150,508,424
36,006,800 shares
|
-$38,525,651 | 31 Dec 2025 |
| William H. Miller III |
13D/G
William H. Miller III Living Trust dated April 17, 2017
|
9.2%
Reported 13D/G
· 26 Jun 2025
|
$154,936,259
34,051,925 shares
|
$0 | 26 Jun 2025 |
| Merck KGaA |
13D/G
Ares Trading SA
|
4.9%
Reported 13D/G
· 09 Jun 2026
|
—
17,467,152 shares
|
$0 | 09 Jun 2026 |
| Point72 Asset Management, L.P. |
13F
13D/G
Company
|
1.9%
Reported 13D/G
· 31 Mar 2026
|
$7,220,070
1,266,679 shares
|
— | 30 Jun 2026 |
| Ares Trading S.A. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$29,112,484
20,647,152 shares
|
— | 12 Oct 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
43
Shares
5,510,498
Rows available
43
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
209
Q3 2026 holders
43
Holder diff
-166
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend